These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 25661065)
41. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells. Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211 [TBL] [Abstract][Full Text] [Related]
42. Functional regulation of Slug/Snail2 is dependent on GSK-3β-mediated phosphorylation. Kim JY; Kim YM; Yang CH; Cho SK; Lee JW; Cho M FEBS J; 2012 Aug; 279(16):2929-39. PubMed ID: 22727060 [TBL] [Abstract][Full Text] [Related]
44. Influenza A virus infection of vascular endothelial cells induces GSK-3β-mediated β-catenin degradation in adherens junctions, with a resultant increase in membrane permeability. Hiyoshi M; Indalao IL; Yano M; Yamane K; Takahashi E; Kido H Arch Virol; 2015 Jan; 160(1):225-34. PubMed ID: 25385175 [TBL] [Abstract][Full Text] [Related]
45. Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin. Ren X; Rizavi HS; Khan MA; Dwivedi Y; Pandey GN Int J Neuropsychopharmacol; 2013 Jun; 16(5):945-55. PubMed ID: 23110823 [TBL] [Abstract][Full Text] [Related]
46. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells. Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667 [TBL] [Abstract][Full Text] [Related]
47. Acceleration of bone development and regeneration through the Wnt/β-catenin signaling pathway in mice heterozygously deficient for GSK-3β. Arioka M; Takahashi-Yanaga F; Sasaki M; Yoshihara T; Morimoto S; Takashima A; Mori Y; Sasaguri T Biochem Biophys Res Commun; 2013 Nov; 440(4):677-82. PubMed ID: 24099767 [TBL] [Abstract][Full Text] [Related]
48. Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3beta-dependent mechanisms. Liu R; Wang L; Chen C; Liu Y; Zhou P; Wang Y; Wang X; Turnbull J; Minassian BA; Liu Y; Zheng P Mol Cell Biol; 2008 Dec; 28(23):7236-44. PubMed ID: 18824542 [TBL] [Abstract][Full Text] [Related]
49. The redox sensitive glycogen synthase kinase 3β suppresses the self-protective antioxidant response in podocytes upon oxidative glomerular injury. Li C; Ge Y; Peng A; Gong R Oncotarget; 2015 Nov; 6(37):39493-506. PubMed ID: 26567873 [TBL] [Abstract][Full Text] [Related]
51. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte. Kim SD; Yang SI; Kim HC; Shin CY; Ko KH Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850 [TBL] [Abstract][Full Text] [Related]
52. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway. Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511 [TBL] [Abstract][Full Text] [Related]
53. New mechanism of rosiglitazone to reduce neointimal hyperplasia: activation of glycogen synthase kinase-3beta followed by inhibition of MMP-9. Lee CS; Kwon YW; Yang HM; Kim SH; Kim TY; Hur J; Park KW; Cho HJ; Kang HJ; Park YB; Kim HS Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):472-9. PubMed ID: 19201691 [TBL] [Abstract][Full Text] [Related]
55. MicroRNA-1246 by Targeting AXIN2 and GSK-3β Overcomes Drug Resistance and Induces Apoptosis in Chemo-resistant Leukemia Cells. Xie B; Li L; Zhang Z; Zhao L; Cheng J; Zhou C; Cheng J; Yan J; Chen J; Yi J; Wang B; Jin S; Wei H J Cancer; 2021; 12(14):4196-4208. PubMed ID: 34093820 [No Abstract] [Full Text] [Related]
56. Dysregulation of miRNAs Levels in Glycogen Synthase Kinase-3β Overexpressing Mice and the Role of miR-221-5p in Synaptic Function. Banach E; Szczepankiewicz A; Kaczmarek L; Jaworski T; Urban-Ciećko J Neuroscience; 2022 May; 490():287-295. PubMed ID: 35331845 [TBL] [Abstract][Full Text] [Related]
57. miR-200 family promotes podocyte differentiation through repression of RSAD2. Li Z; Yin H; Hao S; Wang L; Gao J; Tan X; Yang Z Sci Rep; 2016 Jun; 6():27105. PubMed ID: 27251424 [TBL] [Abstract][Full Text] [Related]
58. Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells. McCubrey JA; Fitzgerald TL; Yang LV; Lertpiriyapong K; Steelman LS; Abrams SL; Montalto G; Cervello M; Neri LM; Cocco L; Martelli AM; Laidler P; Dulińska-Litewka J; Rakus D; Gizak A; Nicoletti F; Falzone L; Candido S; Libra M Oncotarget; 2017 Feb; 8(8):14221-14250. PubMed ID: 27999207 [TBL] [Abstract][Full Text] [Related]
59. Vascular endothelial cell-derived exosomal miR-1246 facilitates posterior capsule opacification development by targeting GSK-3β in diabetes mellitus. Guo C; Zhang J; Wang J; Su L; Ning X; Guo Y; Han J; Ma N Exp Eye Res; 2023 Jun; 231():109463. PubMed ID: 37044287 [TBL] [Abstract][Full Text] [Related]
60. Inhibition of Glycogen Synthase Kinase 3β Blocks Mesomesenchymal Transition and Attenuates Streptococcus pneumonia-Mediated Pleural Injury in Mice. Boren J; Shryock G; Fergis A; Jeffers A; Owens S; Qin W; Koenig KB; Tsukasaki Y; Komatsu S; Ikebe M; Idell S; Tucker TA Am J Pathol; 2017 Nov; 187(11):2461-2472. PubMed ID: 29073967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]